IVD Quality Control Market to Hit $2.2B by 2031 as Automation Drives Growth
Event summary
- The global IVD quality control market is projected to grow from $1.7B in 2026 to $2.2B by 2031, a CAGR of 5.3%.
- Growth is driven by rising testing volumes, regulatory requirements, and the shift to automated QC workflows.
- Roche's navify Lab Operations platform exemplifies the move towards integrated QC management and real-time monitoring.
- Asia-Pacific is the fastest-growing region, with expanding diagnostic infrastructure and laboratory automation.
- Siemens Healthineers earned the My Green Lab ACT Ecolabel for its Atellica analyzers and reagents in July 2025.
The big picture
The IVD quality control market is evolving from a standalone compliance task to an integrated part of laboratory operations. This shift is driven by the increasing complexity of diagnostic testing, regulatory requirements, and the need for real-time quality monitoring. The market's growth is further fueled by the expansion of decentralized and point-of-care testing, creating demand for simplified QC products and quality-management systems.
What we're watching
- Automation Integration
- How the shift from manual to automated QC workflows will impact laboratory efficiency and accuracy.
- Regulatory Compliance
- Whether laboratories can sustain the implementation costs of digital QC systems and staff training.
- Market Expansion
- The pace at which Asia-Pacific can grow its diagnostic infrastructure to support the rising demand for QC solutions.
Related topics
